En revanche, aprs 6 mois de supplmentation, les chercheurs ont dcouvert des amliorations significatives sur les performances des sportifs (+11% en moyenne)
Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial Jensen, Simon Birk Kjr et al
"Additionally, individuals with digestive issues should introduce chia seeds gradually to avoid discomfort." Other than that
Conclusions GLP-1 drugs are increasingly popular for their ability to combat obesity, a significant public health problem in the U.S
Specifically: North Dakota updated its essential health benefit (EHB) benchmark plan under the Affordable Care Act to require, beginning in 2025 , prescription drug coverage of GLP-1s and GIPs as therapy for prevention of diabetes and treatment of insulin resistance, metabolic syndrome or morbid obesity